The stock of Affimed N.V (AFMD) has gone down by -27.47% for the week, with a -21.84% drop in the past month and a -34.14% drop in the past quarter. The volatility ratio for the week is 10.77%, and the volatility levels for the past 30 days are 7.31% for AFMD. The simple moving average for the past 20 days is -20.83% for AFMD’s stock, with a -43.24% simple moving average for the past 200 days.
Is It Worth Investing in Affimed N.V (NASDAQ: AFMD) Right Now?
Moreover, the 36-month beta value for AFMD is 2.10. Analysts have varying opinions on the stock, with 5 analysts rating it as a “buy,” 2 as “overweight,” 2 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for AFMD is 13.02M and currently, short sellers hold a 7.55% of that float. On November 21, 2024, AFMD’s average trading volume was 91.46K shares.
AFMD) stock’s latest price update
Affimed N.V (NASDAQ: AFMD) has experienced a decline in its stock price by -9.33 compared to its previous closing price of 3.00. However, the company has seen a fall of -27.47% in its stock price over the last five trading days. seekingalpha.com reported 2024-11-14 that Affimed N.V. (NASDAQ:AFMD ) Q3 2024 Earnings Call Transcript November 14, 2024 8:30 AM ET Company Participants Alex Fudukidis – Head of Investor Relations & Director of Investor Relations Shawn Leland – Chief Executive Officer Andreas Harstrick – Chief Medical Officer Michael Wolf – Head of Finance & Administration Conference Call Participants Li Watsek – Cantor Daina Graybosch – Leerink Partners Yanan Zhu – Wells Fargo Li Chen – HC Wainright Yale Jen – Laidlaw & Company Dara Azar – Stifel Operator Good day, everyone.
Analysts’ Opinion of AFMD
Many brokerage firms have already submitted their reports for AFMD stocks, with H.C. Wainwright repeating the rating for AFMD by listing it as a “Buy.” The predicted price for AFMD in the upcoming period, according to H.C. Wainwright is $6 based on the research report published on December 12, 2022 of the previous year 2022.
Stifel, on the other hand, stated in their research note that they expect to see AFMD reach a price target of $2, previously predicting the price at $9. The rating they have provided for AFMD stocks is “Hold” according to the report published on October 10th, 2022.
AFMD Trading at -20.74% from the 50-Day Moving Average
After a stumble in the market that brought AFMD to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -69.61% of loss for the given period.
Volatility was left at 7.31%, however, over the last 30 days, the volatility rate increased by 10.77%, as shares sank -19.76% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -29.35% lower at present.
During the last 5 trading sessions, AFMD fell by -27.47%, which changed the moving average for the period of 200-days by -51.76% in comparison to the 20-day moving average, which settled at $3.44. In addition, Affimed N.V saw -56.48% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for AFMD
Current profitability levels for the company are sitting at:
- -30.12 for the present operating margin
- 1.0 for the gross margin
The net margin for Affimed N.V stands at -29.5. The total capital return value is set at -2.21. Equity return is now at value -151.46, with -88.07 for asset returns.
Based on Affimed N.V (AFMD), the company’s capital structure generated 0.25 points at debt to capital in total, while cash flow to debt ratio is standing at -8.9. The debt to equity ratio resting at 0.33. The interest coverage ratio of the stock is -52.57.
Currently, EBITDA for the company is -102.38 million with net debt to EBITDA at -0.05. When we switch over and look at the enterprise to sales, we see a ratio of 16.03. The receivables turnover for the company is 0.47for trailing twelve months and the total asset turnover is 0.05. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.93.
Conclusion
To wrap up, the performance of Affimed N.V (AFMD) has been bad in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
